Patricia Myers

Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.

Cooley advised Vance Street Capital, a Los Angeles-based middle-market private equity firm that invests in highly engineered solutions businesses across the industrial technology, medical, life sciences, aerospace and defense sectors, on its acquisition of System Seals, a designer and manufacturer of custom fluid seals for various industrial applications.

Cooley advised Bluestar Alliance – a company that owns, manages and markets a portfolio of consumer brands that span across many tiers of distribution, from luxury to mass market, with a heavy emphasis on department store retail brands – on its partnership with Hilco Global and TPG Angelo Gordon’s new joint venture.